Install
Eli Lilly
Eli Lilly: hiring, expansion, leadership and results.
- 2 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Eli Lilly
Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes
2+ day, 18+ hour ago (1243+ words) Participants taking EloraTZP lost up to an average of 54.1 lbs (23.3%) compared to 34.4 lbs (14.8%) with tirzepatide 15 mg Participants taking EloraTZP lowered their A1C by up to an average of 2.9% compared to 2.4% with tirzepatide 15 mg Based on results of this 48-week Phase 2b study,…...
Eli Lilly won the first round of the weight-loss boom. Who wins next?
5+ hour, 45+ min ago (1592+ words) Ranked #1 podcast on iTunes financial/business. Frank cuts through the mainstream noise to reveal what’s really moving these markets. Eli Lilly (LLY) has become one of the world’s most valuable companies, with a market cap of roughly $1.1 trillion. And much…...
ELi Lilly-Funded Study Aims to Boost Lp(a) Testing
4+ hour, 41+ min ago (29+ words) Eli Lilly-Funded Study Aims to Boost Lipoprotein(a) Testing to Assess Cardiovascular Disease Risk GenomeWeb Eli Lilly-Funded Study Aims to Boost Lipoprotein(a) Testing to Assess Cardiovascular Disease Risk...
What is Retratrutide? New drug helps diabetes patients lose nearly 19% of body weight
9+ hour, 8+ min ago (301+ words) Published October 13, 2026 In a new Phase III study, the once-weekly injected drug, retatrutide by Eli Lilly, helped obese and diabetic adult participants lose significant weight and improve blood sugar levels. The TRIUMPH-2 study, published in The Lancet, enrolled 1,152 participants at…...
5 Facts on Retatrutide FDA Approval Status in 2026
4+ week, 1+ day ago (1332+ words) Retatrutide is not yet FDA approved. Learn its trial results, timeline, and safer weight loss options available today at InCare. Retatrutide, also known by its research code LY3437943, is not approved by the FDA for any use. This includes obesity, type…...
Retatrutide Shows Up to 20.8% Weight Loss and A1C Reduction in TRIUMPH-2 Trial
1+ week, 6+ day ago (446+ words) Explore Eli Lilly’s Phase 3 TRIUMPH-2 trial results for retatrutide. Discover data on up to 20.8% weight loss, A1C reductions, and cardiometabolic benefits. Written By: Kirti Kumbhar, M. Pharm (QA) Reviewed By: Pharmacally Editorial Team In adults with obesity or overweight and type…...
New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity
4+ day, 14+ hour ago (1088+ words) Exploratory data presented at Fall Clinical 2026 showed broader biomarker changes with Taltz and Zepbound vs. Taltz alone as early as Week 12 in first-of-its-kind TOGETHER-PsO study These data follow previously reported results from TOGETHER-PsO, which showed that Taltz and Zepbound used…...
Lilly is fighting a black market for its new obesity drug even before it launches
1+ day, 10+ hour ago (646+ words) The large pharma’s promising new candidate retatrutide is still in the clinic. But Lilly is already fighting a web of illicit sellers for the drug online. Eli Lilly is no stranger to competition from compounded versions of its tirzepatide GLP…...
This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock
1+ day, 12+ hour ago (383+ words) The Motley Fool Although Eli Lilly (LLY +0.41%) is a leader in the GLP-1 space, the drugmaker continues to develop new and potentially better treatments for people to lose weight. Not everyone has success with GLP-1 drugs or can effectively tolerate…...
Lilly's Zepbound enhances Taltz efficacy in psoriasis study
1+ day, 15+ hour ago (479+ words) A study has shown that the efficacy of Eli Lilly's psoriasis therapy Taltz is improved when it is given in combination with the company's blockbuster weight-loss therapy Zepbound. The results showed that when the two drugs were used together, a…...